AU2209899A - Pyk2 (raftk) and inflammation - Google Patents

Pyk2 (raftk) and inflammation

Info

Publication number
AU2209899A
AU2209899A AU22098/99A AU2209899A AU2209899A AU 2209899 A AU2209899 A AU 2209899A AU 22098/99 A AU22098/99 A AU 22098/99A AU 2209899 A AU2209899 A AU 2209899A AU 2209899 A AU2209899 A AU 2209899A
Authority
AU
Australia
Prior art keywords
raftk
pyk2
inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22098/99A
Other languages
English (en)
Inventor
Mikhail Gishizky
Mitsuhiko Okigaki
Joseph Schlessinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sugen LLC
Original Assignee
Sugen LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen LLC filed Critical Sugen LLC
Publication of AU2209899A publication Critical patent/AU2209899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22098/99A 1998-12-30 1998-12-31 Pyk2 (raftk) and inflammation Abandoned AU2209899A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1998/027871 WO2000040971A1 (en) 1998-12-31 1998-12-31 Pyk2 (raftk) and inflammation
USNOTGIVEN 1999-09-23

Publications (1)

Publication Number Publication Date
AU2209899A true AU2209899A (en) 2000-07-24

Family

ID=22268584

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22098/99A Abandoned AU2209899A (en) 1998-12-30 1998-12-31 Pyk2 (raftk) and inflammation

Country Status (3)

Country Link
EP (1) EP1141722A1 (de)
AU (1) AU2209899A (de)
WO (1) WO2000040971A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1228766A1 (de) * 2001-01-31 2002-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. PYK2 Phosphorylierung durch HER3 induziert Tumorinvasion
EP1401413B1 (de) 2001-06-29 2006-11-22 AB Science Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen
PT1401416E (pt) 2001-06-29 2007-02-28 Ab Science Utilização de inibidores de c-kit para tratar doenças inflamatórias intestinais (dii)
WO2003002105A2 (en) * 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating bone loss
CA2452368A1 (en) 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
WO2003002108A2 (en) 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory diseases
US20050059621A1 (en) * 2003-06-06 2005-03-17 Irene Griswold-Prenner Methods for using modulators of proline-rich tyrosine kinase 2
AR056857A1 (es) 2005-12-30 2007-10-24 U3 Pharma Ag Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
CN105999263B (zh) 2009-11-13 2021-06-29 第一三共欧洲有限公司 用于治疗或预防人表皮生长因子受体-3(her-3)相关疾病的材料和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69734890T2 (de) * 1996-10-11 2006-08-24 New York University Rdgb-proteine
EP0948604B1 (de) * 1996-12-11 2004-07-21 Sugen, Inc. Identifizierungsverfahren für Substanzen die an das Pyk2 Polypeptid binden
WO1998035056A1 (en) * 1997-02-11 1998-08-13 Merck & Co., Inc. Identification of inhibitors of protein tyrosine kinase 2

Also Published As

Publication number Publication date
EP1141722A1 (de) 2001-10-10
WO2000040971A1 (en) 2000-07-13

Similar Documents

Publication Publication Date Title
AU6476599A (en) Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles
AU4208799A (en) Interleukins-21 and 22
AU1268899A (en) Microstrip arrangement
AU4525799A (en) Requirements matching
AU7948298A (en) Microstrip structure
AU9781998A (en) Huchordin and uses thereof
AU1926000A (en) Pth1r and pth3r receptors
AU4198299A (en) Compounds and uses thereof
AU4962499A (en) Solid state microanemometer
AU5921599A (en) Superconducting structure
AU8747998A (en) Anti-inflammatory agent
AU4363999A (en) Novel photoinitiators and their applications
AU1475897A (en) Cellular structure
AU1686600A (en) Chlorophyll-rich and salt-resistant chlorella
AU2397500A (en) Terminal configuration
AUPP433398A0 (en) Compounds and processes
AU2209899A (en) Pyk2 (raftk) and inflammation
AU2396600A (en) Secreted proteins and uses thereof
AU2001239941A1 (en) Beta netrin and uses thereof
AU2155500A (en) Short point anti-cross-threading screw
AU2333099A (en) Aryloxyanilides and related compounds
AU5998199A (en) New bis-benzimidazoles
AU2609599A (en) Sensor-coupling
AU3773299A (en) Lifting-machine power gripper and components
AU2069199A (en) Codelets

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase